Shimadzu’s New FTIR-Based Plastic Analyzer Simplifies Evaluation of Plastic DegradationIdeally Suited for Analyzing Microplastics or Contaminants
Shimadzu’s New FTIR-Based Plastic Analyzer Simplifies Evaluation of Plastic DegradationIdeally Suited for Analyzing Microplastics or Contaminants Shimadzu announces the release of the Plastic Analyzer, a Fourier transform infrared (FTIR) spectrophotometer for evaluating plastic degradation. The system comprises an IRSpirit FTIR spectrophotometer, a Thermal-damaged plastics library, a UV-damaged plastics library (newly released), a Plastic Analyzer method... Read more
Weston Umstead, Ph.D. Promoted to Technology & Business Development Manager for Chiral Technologies, Inc.
Posted December 10, 2020 For Immediate Release Weston Umstead, Ph.D. Promoted to Technology & Business Development Manager for Chiral Technologies, Inc. WEST CHESTER, Pa (December 10, 2020) — Chiral Technologies, Inc. today announced the promotion of Weston Umstead, Ph.D., as the company’s new Technology and Business Development Director. Umstead joined Chiral Technologies in 2016 as... Read more
WITec in Japan and the Chiba Institute of Technology, Japan, cooperate to analyze microplastics (< 20 µm)
WITec GmbH, the German manufacturer of high-performance Raman, AFM, SNOM, and correlative nano-analytical microscopy systems, announces a new cooperation in Japan for particle analysis. Dr. Yutaka Kameda, Associate Professor at the Chiba Institute of Technology (CIT) in Japan, and his team have been working very successfully for several years on the analysis of microplastics in... Read more
Activated Research Company Partners with Shimadzu Scientific Instruments to Offer Jetanizer
The world’s smallest methanizer now available for Shimadzu 2030 GCs Activated Research Company (ARC) is excited to announce that the Jetanizer is now available through Shimadzu Scientific Instruments (SSI) for Shimadzu GC-2030instruments. SSI will be offering the Jetanizer through its headquarters in Columbia, MD directly to end users in the US and to Shimadzu subsidiaries throughout... Read more
Amphenol Corporation to Acquire MTS Systems
WALLINGFORD, Conn. & EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Dec. 9, 2020– Amphenol Corporation (NYSE: APH) (“Amphenol”), a leading global provider of high-technology interconnect, antenna and sensor solutions, and MTS Systems Corporation (Nasdaq: MTSC) (“MTS”), a leading global supplier of advanced test systems, motion simulators and precision sensors, today announced that they have entered into a definitive agreement... Read more
Thermo Fisher Scientific Further Expands Global Footprint for Drug Product Development and Commercial Manufacturing
Thermo Fisher Scientific Further Expands Global Footprint for Drug Product Development and Commercial Manufacturing WALTHAM, Mass., Dec. 9, 2020 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced it will further expand its footprint in North America and Europe for sterile drug product development and commercial manufacturing of critical medicines, therapies... Read more
Roche partners with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trials
Moderna’s vaccine triggers an antibody response to the SARS-CoV-2 spike protein The Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in vaccine trial participants and could help to establish correlation to protection from COVID-19 Emergency Use Authorisation by the US FDA for the Elecsys Ab test was granted on 25... Read more
Thermo Fisher Scientific Gains CE Mark Certification for New OmniPATH Combi SARS-CoV-2 IgG ELISA Test
Quantifying IgG is critical component to test population-wide vaccination effectiveness Read more
Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing
SAN DIEGO & WELLESLEY, Mass.–(BUSINESS WIRE)–Illumina, Inc. (Nasdaq: ILMN) and Harvard Pilgrim Health Care announce a risk-sharing agreement to make whole-genome sequencing (WGS) available to certain Harvard Pilgrim members, effective January 1, 2021. The program will leverage WGS to support faster diagnoses of genetic diseases in children, potentially eliminating the long, costly diagnostic odyssey experienced... Read more